Combining Treg therapy with mixed chimerism: Getting the best of both worlds

Chimerism

Volumn 1, Issue 1, 2010, Pages 26-29

  Pilat, Nina ^a   Wekerle, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bone marrow transplantation; Mixed chimerism; Regulatory T cells (Tregs); Tolerance; Transplantation

Indexed keywords

ABATACEPT; CD40 LIGAND; RAPAMYCIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CLINICAL EFFECTIVENESS; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; IRRADIATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; REGULATORY T LYMPHOCYTE; SKIN GRAFT; T CELL DEPLETION; T LYMPHOCYTE;

EID: 78649638238     PISSN: 19381956     EISSN: 19381964     Source Type: Journal    
DOI: 10.4161/chim.1.1.12964     Document Type: Article

References (36)

1. Wekerle T, Sykes M. Mixed chimerism and transplantation tolerance. Annu Rev Med 2001; 52:353-70.
2. Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, et al. HLAmismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358:353-61.
3. Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008; 358:362-8.
4. Fehr T, Sykes M. Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl Int 2008; 21:1118-35.
5. Wekerle T, Nikolic B, Pearson DA, Swenson KG, Sykes M. Minimal conditioning required in a murine model of T cell depletion, thymic irradiation and high-dose bone marrow transplantation for the induction of mixed chimerism and tolerance. Transpl Int 2002; 15:248-53.
6. Sykes M, Szot GL, Swenson K, Pearson DA. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nature Med 1997; 3:783-7.
7. Wekerle T, Kurtz J, Ito H, Ronquillo JV, Dong V, Zhao G, et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nature Med 2000; 6:464-9.
8. Durham MM, Bingaman AW, Adams AB, Ha J, Waitze SY, Pearson TC, et al. Administration of anti-CD40 ligand and donor bone marrow leads to hematopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol 2000; 165:1-4.
9. Riley JL, June CH, Blazar BR. Human T regulatory cell therapy: Take a billion or so and call me in the morning. Immunity 2009; 30:656-65.
10. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alphachains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-64.
11. Jaeckel E, von Boehmer H, Manns M. Antigenspecific Foxp3 transduced T cells can control established Type 1 diabetes. Diabetes 2005; 54:306-10.
12. Baecher-Allan C, Hafler DA. Human regulatory T cells and their role in autoimmune disease. Immunol Rev 2006; 212:203-16.
13. + regulatory T cells rescue scurfy mice. Eur J Immunol 2008; 38:1814-21.
14. + regulatory T cells cure murine colitis: the role of IL-10, TGF-β and CTLA4. J Immunol 2003; 171:5012-7.
15. + regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation. Blood 2005; 105:4871-7.
16. Nadig SN, Wieckiewicz J, Wu DC, Warnecke G, Zhang W, Luo S, et al. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med 2010; 16:809-13.
17. - T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 2005; 79:1310-6.
18. + Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest 2008; 118:3619-28.
19. Battaglia M. Potential T regulatory cell therapy in transplantation: how far have we come and how far can we go? Transpl Int 2010; 23:761-70.
20. Pilat N, Baranyi U, Klaus C, Jaeckel E, Mpofu N, Wrba F, et al. Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning. Am J Transpl 2010; 10:751-62.
21. Williams MA, Trambley J, Ha J, Adams AB, Durham MM, Rees P, et al. Genetic characterization of strain differences in the ability to mediate CD40/CD28- independent rejection of skin allografts. J Immunol 2000; 165:6849-57.
22. Wekerle T, Blaha P, Langer F, Schmid M, Muehlbacher F. Tolerance through bone marrow transplantation with costimulation blockade. Transpl Immunol 2002; 9:125-33.
23. Waldmann H, Adams E, Fairchild P, Cobbold S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol Rev 2006; 212:301-13.
24. + T helper cells. J Exp Med 2002; 196:255-60.
25. Wekerle T, Sayegh MH, Hill J, Zhao Y, Chandraker A, Swenson KG, et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998; 187:2037-44.
26. Taylor PA, Lees CJ, Waldmann H, Noelle RJ, Blazar BR. Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions. Blood 2001; 98:467-74.
27. Wekerle T, Sayegh MH, Ito H, Hill J, Chandraker A, Pearson DA, et al. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a nonmyeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation 1999; 68:1348-55.
28. Bigenzahn S, Blaha P, Koporc Z, Pree I, Selzer E, Bergmeister H, et al. The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. Am J Transplant 2005; 5:1237-47.
29. Domenig C, Sanchez-Fueyo A, Kurtz J, Alexopoulos SP, Mariat C, Sykes M, et al. Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol. J Immunol 2005; 175:51-60.
30. Kurtz J, Wekerle T, Sykes M. Tolerance in mixed chimerism- a role for regulatory cells? Trends Immunol 2004; 25:518-23.
31. Blaha P, Bigenzahn S, Koporc Z, Schmid M, Langer F, Selzer E, et al. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 2003; 101:2886-93.
32. Taylor PA, Lees CJ, Wilson JM, Ehrhardt MJ, Campbell MT, Noelle RJ, et al. Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions. Blood 2002; 100:3400-7.
33. Blaha P, Bigenzahn S, Koporc Z, Sykes M, Muehlbacher F, Wekerle T. Short-term immunosuppression facilitates induction of mixed chimerism and tolerance after bone marrow transplantation without cytoreductive conditioning. Transplantation 2005; 80:237-43.
34. + regulatory T cells. Blood 2005; 105:4743-8.
35. Thomson AW, Turnquist HR, Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 2009; 9:324-37.
36. Porcheray F, Wong W, Saidman SL, De Vito J, Girouard TC, Chittenden M, et al. B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant 2009; 9:2126-35.